(Q35906870)

11 August 2017

1 reference

title

Methodology of measuring the efficacy of antidepressants (English)

1 reference

11 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1546150

7 October 2022

1

Quitkin FM

1 reference

11 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1546150

7 October 2022

publication date

1 January 1992

1 reference

11 August 2017

1 reference

11 August 2017

106 Suppl

1 reference

11 August 2017

S87-9

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02246244

11 August 2017

0 references

cites work

Duration of antidepressant drug treatment. What is an adequate trial?

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246244

Use of pattern analysis to identify true drug response. A replication

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246244

A multiple-dose, controlled study of phenelzine in depression-anxiety states.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246244

Clinical and pharmacokinetic factors affecting response to phenelzine

21 January 2018

1 reference

12 December 2020

Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression

1 reference

12 December 2020

Family practitioners' knowledge about treatment of depressive illness

1 reference

12 December 2020

Treatment received by depressed patients

1 reference

12 December 2020

Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety

1 reference

12 December 2020

Two dosages of imipramine in hospitalized endogenous and neurotic depressives

1 reference

12 December 2020

Amoxapine: a review of its pharmacology and efficacy in depressed states

1 reference

12 December 2020

Study duration in antidepressant research: advantages of a 12-week trial

1 reference

12 December 2020

Metabolism, anticholinergic effects, and therapeutic outcome of desmethylimipramine in depressive illness

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02246244

1 reference

11 August 2017

1 reference